Florida Cancer Specialists & Research Institute (FCS) is pleased to announce that Michael Diaz, MD will assume the role of President & Managing Physician, effective January 1, 2022. He succeeds Lucio Gordan, MD, who has served in that position since 2018. Dr. Gordan will continue to practice as a medical oncologist at the FCS Gainesville Cancer Center and serve as Chief Medical Officer of Therapeutics and Analytics for the statewide practice.
Senior leaders of Florida Cancer Specialists & Research Institute (FCS) have been invited to serve on the faculty for the Association for Value-Based Cancer Care 2021 Summit & Educational Program being held in New York, NY on Oct. 13 – 15.
FCS clinical oncology nutritionist Rhone M. Levin, M.Ed, RDN, CSO, LDN, FAND, is the author of the nutrition chapter featured in the recently published 5th Edition of Lung Cancer Choices.
Sarah Cannon recently opened its newest drug development unit in collaboration with FCS and The University of Central Florida College of Medicine in Lake Nona, Fla.
A panel of medical experts recently provided the latest updates about COVID-19 and fielded questions from local residents. COVID-19: Speaking from Science, presented by Florida Cancer Specialists & Research Institute (FCS) in partnership with the Leesburg Area Chamber of Commerce, the City of Leesburg and Red Apples Media was held on Saturday, Aug. 28.
In a recent evaluation, empirical data indicates FCS decreased emergency room visits not resulting in an admission or observation stay by 18% and decreased inpatient hospital admissions by 15% from 2017 – 2020.
FCS Top News Updates
FCS Contributing To Breakthroughs In Treatment of Blood Cancers & Disorders
Florida Cancer Specialists & Research Institute Names Michael Diaz, MD as President & Managing PhysicianFlorida Cancer Specialists & Research Institute (FCS) is pleased to announce that Michael Diaz, MD will assume the role of President & Managing Physician, effective January 1, 2022. He succeeds Lucio Gordan, MD, who has served in that position since 2018. Dr. Gordan will continue to practice as a medical oncologist at the FCS Gainesville Cancer Center and serve as Chief Medical Officer of Therapeutics and Analytics for the statewide practice.
FCS Leaders Serve on 2021 Faculty for Value-Based Cancer Care SummitSenior leaders of Florida Cancer Specialists & Research Institute (FCS) have been invited to serve on the faculty for the Association for Value-Based Cancer Care 2021 Summit & Educational Program being held in New York, NY on Oct. 13 – 15.
Oncology Nutritionist Rhone M. Levin Published in 5th Edition of Lung Cancer ChoicesFCS clinical oncology nutritionist Rhone M. Levin, M.Ed, RDN, CSO, LDN, FAND, is the author of the nutrition chapter featured in the recently published 5th Edition of Lung Cancer Choices.
Sarah Cannon Announces Opening of Oncology Drug Development Unit in Collaboration with Florida Cancer Specialists & Research Institute and The University of Central Florida in Lake NonaSarah Cannon recently opened its newest drug development unit in collaboration with FCS and The University of Central Florida College of Medicine in Lake Nona, Fla.
Research Conducted by FCS Presented at European Society of Medical Oncology 2021 CongressFour FCS physicians are the authors of five cancer research studies that will be presented at European Society of Medical Oncology 2021.
Local Physician Experts Provide COVID-19 Updates At Community Sponsored EventA panel of medical experts recently provided the latest updates about COVID-19 and fielded questions from local residents. COVID-19: Speaking from Science, presented by Florida Cancer Specialists & Research Institute (FCS) in partnership with the Leesburg Area Chamber of Commerce, the City of Leesburg and Red Apples Media was held on Saturday, Aug. 28.
FCS on the Forefront of Immunotheraphy Treatment Advancements for Cancer PatientsFCS continues to expand the number and scope of clinical trial opportunities available to cancer patients in the community setting.
FCS Integrated Value-Based Care Model Improves Quality & Patient OutcomesIn a recent evaluation, empirical data indicates FCS decreased emergency room visits not resulting in an admission or observation stay by 18% and decreased inpatient hospital admissions by 15% from 2017 – 2020.